These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

226 related items for PubMed ID: 24956561

  • 1. Pramipexole but not imipramine or fluoxetine reverses the "depressive-like" behaviour in a rat model of preclinical stages of Parkinson's disease.
    Berghauzen-Maciejewska K, Kuter K, Kolasiewicz W, Głowacka U, Dziubina A, Ossowska K, Wardas J.
    Behav Brain Res; 2014 Sep 01; 271():343-53. PubMed ID: 24956561
    [Abstract] [Full Text] [Related]

  • 2. Alterations of BDNF and trkB mRNA expression in the 6-hydroxydopamine-induced model of preclinical stages of Parkinson's disease: an influence of chronic pramipexole in rats.
    Berghauzen-Maciejewska K, Wardas J, Kosmowska B, Głowacka U, Kuter K, Ossowska K.
    PLoS One; 2015 Sep 01; 10(3):e0117698. PubMed ID: 25739024
    [Abstract] [Full Text] [Related]

  • 3. Adaptive down-regulation of the serotonin transporter in the 6-hydroxydopamine-induced rat model of preclinical stages of Parkinson's disease and after chronic pramipexole treatment.
    Berghauzen-Maciejewska K, Wardas J, Kosmowska B, Domin H, Śmiałowska M, Głowacka U, Ossowska K.
    Neuroscience; 2016 Feb 09; 314():22-34. PubMed ID: 26628402
    [Abstract] [Full Text] [Related]

  • 4. Mechanism of synergistic action following co-treatment with pramipexole and fluoxetine or sertraline in the forced swimming test in rats.
    Rogóz Z, Skuza G.
    Pharmacol Rep; 2006 Feb 09; 58(4):493-500. PubMed ID: 16963794
    [Abstract] [Full Text] [Related]

  • 5. Antidepressant effects of pramipexole, a novel dopamine receptor agonist.
    Maj J, Rogóz Z, Skuza G, Kołodziejczyk K.
    J Neural Transm (Vienna); 1997 Feb 09; 104(4-5):525-33. PubMed ID: 9295183
    [Abstract] [Full Text] [Related]

  • 6. Effects of pramipexole on the duration of immobility during the forced swim test in normal and ACTH-treated rats.
    Kitagawa K, Kitamura Y, Miyazaki T, Miyaoka J, Kawasaki H, Asanuma M, Sendo T, Gomita Y.
    Naunyn Schmiedebergs Arch Pharmacol; 2009 Jul 09; 380(1):59-66. PubMed ID: 19274453
    [Abstract] [Full Text] [Related]

  • 7. Pramipexole for the treatment of depressive symptoms in patients with Parkinson's disease: a randomised, double-blind, placebo-controlled trial.
    Barone P, Poewe W, Albrecht S, Debieuvre C, Massey D, Rascol O, Tolosa E, Weintraub D.
    Lancet Neurol; 2010 Jun 09; 9(6):573-80. PubMed ID: 20452823
    [Abstract] [Full Text] [Related]

  • 8. Anterior ventral tegmental area dopaminergic neurons are not involved in the motivational effects of bromocriptine, pramipexole and cocaine in drug-free rats.
    Ouachikh O, Dieb W, Durif F, Hafidi A.
    Behav Brain Res; 2014 Apr 01; 262():1-7. PubMed ID: 24361908
    [Abstract] [Full Text] [Related]

  • 9. Pharmacologically distinct pramipexole-mediated akinesia vs. risk-taking in a rat model of Parkinson's disease.
    Holtz NA, Tedford SE, Persons AL, Grasso SA, Napier TC.
    Prog Neuropsychopharmacol Biol Psychiatry; 2016 Oct 03; 70():77-84. PubMed ID: 27216282
    [Abstract] [Full Text] [Related]

  • 10. Pramipexole is active in depression tests and modulates monoaminergic transmission, but not brain levels of BDNF in mice.
    Schulte-Herbrüggen O, Vogt MA, Hörtnagl H, Gass P, Hellweg R.
    Eur J Pharmacol; 2012 Feb 29; 677(1-3):77-86. PubMed ID: 22206815
    [Abstract] [Full Text] [Related]

  • 11. Antidepressant-like properties of the anti-Parkinson agent, piribedil, in rodents: mediation by dopamine D2 receptors.
    Brocco M, Dekeyne A, Papp M, Millan MJ.
    Behav Pharmacol; 2006 Nov 29; 17(7):559-72. PubMed ID: 17021388
    [Abstract] [Full Text] [Related]

  • 12. Partial loss of dopaminergic neurons in the substantia nigra, ventrotegmental area and the retrorubral area -- model of the early beginning of Parkinson's symptomatology?
    Heim C, Sova L, Kurz T, Kolasiewicz W, Schwegler H, Sontag KH.
    J Neural Transm (Vienna); 2002 May 29; 109(5-6):691-709. PubMed ID: 12111461
    [Abstract] [Full Text] [Related]

  • 13. 1,2,3,4-Tetrahydroisoquinoline produces an antidepressant-like effect in the forced swim test and chronic mild stress model of depression in the rat: Neurochemical correlates.
    Możdżeń E, Papp M, Gruca P, Wąsik A, Romańska I, Michaluk J, Antkiewicz-Michaluk L.
    Eur J Pharmacol; 2014 Apr 15; 729():107-15. PubMed ID: 24561050
    [Abstract] [Full Text] [Related]

  • 14. Antidepressant effects of pramipexole, a dopamine D3/D2 receptor agonist, and 7-OH-DPAT, a dopamine D3 receptor agonist, in olfactory bulbectomized rats.
    Breuer ME, Groenink L, Oosting RS, Buerger E, Korte M, Ferger B, Olivier B.
    Eur J Pharmacol; 2009 Aug 15; 616(1-3):134-40. PubMed ID: 19549514
    [Abstract] [Full Text] [Related]

  • 15. Effects of ketamine on vocal impairment, gait changes, and anhedonia induced by bilateral 6-OHDA infusion into the substantia nigra pars compacta in rats: Therapeutic implications for Parkinson's disease.
    Vecchia DD, Kanazawa LKS, Wendler E, de Almeida Soares Hocayen P, Bruginski E, Campos FR, Stern CAJ, Vital MABF, Miyoshi E, Wöhr M, Schwarting RKW, Andreatini R.
    Behav Brain Res; 2018 Apr 16; 342():1-10. PubMed ID: 29307665
    [Abstract] [Full Text] [Related]

  • 16. New dopamine agonist pramipexole improves parkinsonism and depression in Parkinson's disease.
    Harada T, Ishizaki F, Horie N, Nitta Y, Yamada T, Sasaki T, Nagakane T, Yasumatsu Y, Nitta K, Katsuoka H.
    Hiroshima J Med Sci; 2011 Dec 16; 60(4):79-82. PubMed ID: 22389951
    [Abstract] [Full Text] [Related]

  • 17. The nonsteroidal antiinflammatory drug piroxicam reverses the onset of depressive-like behavior in 6-OHDA animal model of Parkinson's disease.
    Santiago RM, Tonin FS, Barbiero J, Zaminelli T, Boschen SL, Andreatini R, Da Cunha C, Lima MM, Vital MA.
    Neuroscience; 2015 Aug 06; 300():246-53. PubMed ID: 25999296
    [Abstract] [Full Text] [Related]

  • 18. Lesions of dopaminergic neurons in the substantia nigra pars compacta and in the ventral tegmental area enhance depressive-like behavior in rats.
    Winter C, von Rumohr A, Mundt A, Petrus D, Klein J, Lee T, Morgenstern R, Kupsch A, Juckel G.
    Behav Brain Res; 2007 Dec 03; 184(2):133-41. PubMed ID: 17698212
    [Abstract] [Full Text] [Related]

  • 19. Early L-dopa, but not pramipexole, restores basal ganglia activity in partially 6-OHDA-lesioned rats.
    Marin C, Bonastre M, Mengod G, Cortés R, Giralt A, Obeso JA, Schapira AH.
    Neurobiol Dis; 2014 Apr 03; 64():36-47. PubMed ID: 24370700
    [Abstract] [Full Text] [Related]

  • 20. Ketamine reversed short-term memory impairment and depressive-like behavior in animal model of Parkinson's disease.
    Vecchia DD, Kanazawa LKS, Wendler E, Hocayen PAS, Vital MABF, Takahashi RN, Da Cunha C, Miyoshi E, Andreatini R.
    Brain Res Bull; 2021 Mar 03; 168():63-73. PubMed ID: 33359641
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.